Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Aligos Therapeutics (ALGS) Other Gross PP&E Adjustments (2021 - 2025)

Aligos Therapeutics' Other Gross PP&E Adjustments history spans 5 years, with the latest figure at $9.8 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 28.35% year-over-year to $9.8 million; the TTM value through Dec 2025 reached $9.8 million, up 28.35%, while the annual FY2025 figure was $9.8 million, 28.35% up from the prior year.
  • Other Gross PP&E Adjustments reached $9.8 million in Q4 2025 per ALGS's latest filing, down from $10.9 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $10.9 million in Q3 2025 to a low of $3.4 million in Q4 2021.
  • Average Other Gross PP&E Adjustments over 5 years is $7.1 million, with a median of $7.1 million recorded in 2023.
  • Peak YoY movement for Other Gross PP&E Adjustments: fell 7.3% in 2022, then surged 60.83% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $3.4 million in 2021, then surged by 34.74% to $4.6 million in 2022, then rose by 2.38% to $4.7 million in 2023, then surged by 60.83% to $7.6 million in 2024, then increased by 28.35% to $9.8 million in 2025.
  • Per Business Quant, the three most recent readings for ALGS's Other Gross PP&E Adjustments are $9.8 million (Q4 2025), $10.9 million (Q3 2025), and $10.2 million (Q2 2025).